Menveo is a vaccine used to protect against meningococcal disease. Specifically, MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 2 months through 55 years of age (06-Sept-2024).
In simpler terms:
- Purpose: Prevention of meningococcal disease
- Target Pathogens: Neisseria meningitidis serogroups A, C, Y, and W-135
- Age Range: Individuals aged 2 months to 55 years.
